1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 7,640 | 7,900 | 05.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.07. | SMAIO Reports Sales for the First Half of 2026 | 342 | Business Wire | Up 3% to €5.1m, first-half sales exceeded the €5m mark for the first time, despite four months of temporary absence of one of the top-performing surgeons in the United States
U.S. sales... ► Artikel lesen | |
| 12.05. | SMAIO Reported Revenue of €2.8 Million in the First Quarter of 2026, an Increase of 11% | 391 | Business Wire | Revenue in the United States reached a record quarterly high of €2.3 million (+21%), or $2.6 million (+35%)1 excluding currency effects
The United States accounts for nearly 80% of the... ► Artikel lesen | |
| 11.05. | SMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon | 350 | Business Wire | Appointment of Dr. Jeffrey M. Hills, an orthopedic surgeon specializing in complex spinal conditions SMAIO's Scientific Advisory Board, now comprised of five members, is a key asset in... ► Artikel lesen | |
| 05.05. | SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating | 473 | Business Wire | Regulatory News:
SMAIO (Software, Machines and Adaptive Implants in Orthopaedics Euronext Growth Paris, ISIN Code: FR0014005I80 Ticker: ALSMA), a French-American company specialized in complex... ► Artikel lesen | |
| S.M.A.I.O SA Aktie jetzt für 0€ handeln | |||||
| 06.03. | SMAIO Announces a €3.6 Million Capital Increase to Support Its Long-Term Growth Momentum | 544 | Business Wire | Capital increase totaling €3.6 million gross through the issuance of shares with stock warrants (ABSAs) at a price of €7 per share
4 warrants will entitle the holder to subscribe for one... ► Artikel lesen | |
| 20.01. | SMAIO Reports 2025 Sales of €9.2m, Representing an Increase of +67% | 444 | Business Wire | U.S. sales rose by +138% to €7m, and by +160% to $7.9m (excluding currency effects).
Strong growth across North American centers that were already active in 2024 (+130%). 11 new... ► Artikel lesen | |
| 08.01. | SMAIO: 2026 Financial Calendar | 545 | Business Wire | Regulatory News:
SMAIO (Software, Machines and Adaptive Implants in Orthopaedics Euronext Growth Paris, ISIN: FR0014005I80 Ticker: ALSMA), a French-American player specialized in complex spine... ► Artikel lesen | |
| 06.01. | SMAIO Obtains €2.0m in Non-Dilutive Financing | 502 | Business Wire | €1.0m in the form of a 0% interest loan co-financed by the European Union, the Auvergne-Rhône-Alpes Region and Bpifrance, with a repayment deferral period of two and a half years €1.0m... ► Artikel lesen | |
| 19.12.25 | SMAIO Successfully Continues Its Think Tanks Focused on Promoting Its Innovative Solutions in the United States | 729 | Business Wire | New attendance record at the New York session, bringing together nearly 60 experts from the spine sector, including over 40 surgeons
Regulatory News:
SMAIO (Software, Machines and Adaptative... ► Artikel lesen | |
| 24.11.25 | SMAIO Appoints Matthieu Ville as Chief Commercial Officer to Accelerate Commercialization and Strengthen Its Leadership in Spinal Realignment | 382 | Business Wire | Matthieu Ville brings over 15 years of experience in medical marketing in the United States.
Regulatory News:
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics- Euronext Growth... ► Artikel lesen | |
| 03.11.25 | SMAIO Adds a New High-Profile Member to Its Scientific Advisory Board in the United States | 411 | Business Wire | Appointment of Dr. Tenner Guillaume, Orthopaedic spine surgeon who specializes in spinal deformity at Gillette Children's Hospital (St. Paul, Minnesota). SMAIO's US scientific advisory board... ► Artikel lesen | |
| 22.10.25 | SMAIO Signs a New Distribution Agreement for Its Open Platform KEOPS-4ME With Orthofix in the U.S. | 579 | Business Wire | Orthofix is a global medical technology company focused on healing musculoskeletal pathologies The distribution arrangement is part of SMAIO's collaborative strategy aimed at deploying... ► Artikel lesen | |
| 14.10.25 | SMAIO Announces Strong First-Half 2025 Results and Robust Growth in Business Activity in the Third Quarter of 2025 | 376 | Business Wire | Strong sales growth in H1 2025: +126% to €5.0 million
Increase in gross margin in H1 2025 to 85% vs. 64% in H1 2024
Significant improvement in EBITDA (+96%) reaching break-even (vs.... ► Artikel lesen | |
| 24.09.25 | SMAIO Signs the First Major Distribution Agreement for Its Open Platform KEOPS-4ME with Highridge Medical in the U.S. | 474 | Business Wire | Highridge Medical is one of the world's largest privately held spine companies The partnership represents a key milestone in further expanding SMAIO's business activity in the U.S. and driving... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,650 | +5,16 % | EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose für das Geschäftsjahr 2026 an | EQS-Ad-hoc: Fresenius SE & Co. KGaA / Schlagwort(e): Prognose / Gesamtjahr
Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,310 | -0,36 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,240 | +0,62 % | Siemens Healthineers AG: Gemischtes Q3: Schwäche im Diagnostikbereich mindert robuste Kernleistung. KAUFEN. | Siemens Healthineers (SHL) berichtete über gemischte Ergebnisse für das dritte Quartal 2026, mit moderatem vergleichbarem Umsatzwachstum und bereinigtem EPS, unterstützt durch Rückerstattungen von US-Zöllen.... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,02 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,370 | +0,16 % | Jefferies senkt Kursziel für Procept BioRobotics nach verfehlten Eingriffszahlen | ||
| AUTONOMIX MEDICAL | 12,100 | 0,00 % | Morning Market Movers: Gran Tierra Energy, Autonomix Medical, Julong Holding, Shopify See Big Swings | OTTAWA (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BILLIONTOONE | 149,96 | -0,01 % | BillionToOne Q2 2026 slides: 64% revenue growth, shares plunge 30% | ||
| PACS GROUP | 45,630 | 0,00 % | Hohes Handelsaufkommen bei Optionen der Pacs Group | ||
| ALIGNMENT HEALTHCARE | 13,680 | 0,00 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| ADAPTHEALTH | 6,490 | -0,08 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 30,280 | -2,20 % | EQS-AFR: Carl Zeiss Meditec AG: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen | EQS Vorabbekanntmachung Finanzberichte: Carl Zeiss Meditec AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Carl Zeiss Meditec AG: Vorabbekanntmachung... ► Artikel lesen | |
| GENEDX | 69,95 | +0,06 % | Cathie Wood's ARK sells Palantir stock, buys GeneDx Holdings | ||
| BLUEJAY DIAGNOSTICS | 1,240 | 0,00 % | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study | ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today... ► Artikel lesen | |
| AGILON HEALTH | 107,62 | -0,06 % | agilon health, inc. - 8-K, Current Report | ||
| GERRESHEIMER | 26,360 | -3,51 % | UBS stuft GERRESHEIMER AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Gerresheimer auf "Sell" mit einem Kursziel von 12,90 Euro belassen. Der angekündigte Verkauf der US-Tochter Centor sowie... ► Artikel lesen |
S.M.A.I.O SA gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 7,620 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu S.M.A.I.O SA finden Sie auf Wallstreet Online.